← All trials
NCT02153879
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2009
- Primary completion
- Dec 1, 2011
- Completion date
- Dec 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 30
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Rovira i Virgili UniversityLead sponsor
- Rovira i Virgili UniversityReponsible party - principal investigator
- Rovira i Virgili UniversityStudy director
- Spanish Biomedical Research Centre in Diabetes and Associated Metabolic DisordersCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.